Form 4: Clover Health Director Carladenise Edwards Sells $722,000 in Shares

Director Carladenise Edwards sold 200,000 shares of Clover Health Investments, CORP. on March 7, 2025, at an average price of $3.61 per share.

Summary

• On March 7, 2025, Carladenise Edwards, a director of Clover Health Investments, CORP., sold 200,000 shares of Class A Common Stock.
• The sale was executed at a weighted average price of $3.61 per share, resulting in a total transaction value of approximately $722,000.
• Following the transaction, Edwards directly owns 273,227 shares of Clover Health Investments, CORP.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock sale by a company director. It doesn't inherently convey positive or negative sentiment, but the sale itself could be interpreted in various ways by investors.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, such as directors and officers, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors for signals about a company's prospects.

Stakeholder Impact

• The stock sale by a director could influence investor sentiment, potentially affecting the stock price.
• The transaction provides transparency to shareholders regarding insider trading activity.

Key Dates